Alembic Pharmaceuticals Ltd. - Research Center
533573 APLLTD Group (A) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Sales | 1,475.56 | 1,474.55 | 1,588.39 | 1,478.84 | 1,332.27 |
| Operating profit | 291.42 | 288.19 | 337.14 | 207.46 | 165.73 |
| Interest | 12.69 | 10.13 | 14.66 | 15.39 | 14.29 |
| Gross profit | 281.88 | 285.28 | 325.78 | 201.03 | 163.28 |
| EPS (Rs) | 8.96 | 10.27 | 11.87 | 6.81 | 4.96 |
Quarterly
results in details
| Jun' 24 | Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | |
|---|---|---|---|---|---|
| Other income | 3.15 | 7.22 | 3.30 | 8.95 | 11.84 |
| Stock adjustment | -111.68 | -25.25 | 10.15 | -30.07 | -7.20 |
| Raw material | 405.93 | 337.38 | 317.58 | 413.87 | 334.19 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 356.51 | 354.92 | 327.11 | 326.41 | 327.47 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 533.37 | 519.31 | 596.41 | 561.18 | 512.09 |
| Provisions made | - | - | - | - | - |
| Depreciation | 68.68 | 69.12 | 69.08 | 67.18 | 65.75 |
| Taxation | 37.01 | 14.29 | 23.46 | - | - |
| Net profit / loss | 176.19 | 201.87 | 233.24 | 133.84 | 97.53 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 19.75 | 19.54 | 21.23 | 14.03 | 12.44 |
| GPM (%) | 19.06 | 19.25 | 20.47 | 13.51 | 12.15 |
| NPM (%) | 11.92 | 13.62 | 14.65 | 9.00 | 7.26 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis